ArticleArchives of microbiology2026
Boosting phenazine-1-carboxylic acid (PCA) yield in Pseudomonas aeruginosa and assessing antifungal performance of PCA-loaded mesoporous carriers.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phenazine-1-carboxylic acid (PCA) is a potent antifungal metabolite from Pseudomonas aeruginosa, but its application is limited by low production yields and stability issues. This study aimed to enhance PCA production and evaluate its efficacy using a nano-delivery system. We employed a two-stage statistical optimization strategy. First, a Plackett-Burman (PB) design identified pH, temperature, and glycerol concentration as critical factors. Subsequently, Response Surface Methodology (RSM) based on a Central Composite Design (CCD) was used to fine-tune these parameters. The optimal conditions of pH 7.2, 30 °C, 2% glycerol, and 200 rpm agitation resulted in a significant 2.5-fold increase in PCA yield. The antifungal activity of the optimized PCA was then evaluated against major plant pathogens, including Alternaria solani and Fusarium oxysporum. Both free PCA and a novel PCA-loaded mesoporous silica carrier exhibited potent antifungal effects. Mechanistic studies revealed this activity stems from disrupting fungal electron transport chains and compromising cell membrane integrity. These results demonstrate a robust, dual-pronged framework that improves both the production efficiency and functional performance of PCA. This integrated bioprocess-nanotechnology approach offers a promising and sustainable platform for developing PCA as an effective agricultural biocontrol agent and contributes toward broader efforts to combat plant diseases and antimicrobial resistance.
Indexed as
Identifiers
41627497What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.